Filtros de búsqueda

Lista de obras de Anne-Geneviève Marcelin

A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure

article

A polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activity

artículo científico publicado en 2013

A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletion

artículo científico publicado en 2013

A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART

artículo científico publicado en 2014

Absence of a link between human herpesvirus 8 and pemphigus

artículo científico publicado en 1999

Addition of Etravirine Does Not Enhance the Initial Decline of HIV-1 RNA in Treatment-Experienced Patients Receiving Raltegravir

artículo científico publicado en 2017

Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward

artículo científico publicado en 2020

Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients

artículo científico publicado en 2009

Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study

artículo científico publicado en 2019

Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy

artículo científico publicado en 2008

Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response

artículo científico publicado en 2014

Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

artículo científico publicado en 2014

Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma

artículo científico publicado en 2017

Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients

artículo científico publicado en 2006

Bridging β-Cyclodextrin Prevents Self-Inclusion, Promotes Supramolecular Polymerization, and Promotes Cooperative Interaction with Nucleic Acids

artículo científico publicado en 2018

Caution is needed in interpreting HIV transmission chains by ultradeep sequencing

scientific article published on 01 March 2019

Characterization and structural analysis of HIV-1 integrase conservation

artículo científico publicado en 2009

Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting

artículo científico publicado en 2012

Characterization of a <i>Cutibacterium acnes</i> Camp Factor 1-Related Peptide as a New TLR-2 Modulator in In Vitro and Ex Vivo Models of Inflammation

artículo científico publicado en 2022

Characterization of a Propionibacterium acnes Surface Protein as a Fibrinogen-Binding Protein

artículo científico publicado en 2017

Characterization of drug resistance and the defective HIV reservoir in virally suppressed vertically infected children in Mali

scientific article published on 19 February 2020

Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20.

artículo científico publicado en 2004

Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial)

scientific article published on 07 April 2020

Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification

article

Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.

artículo científico publicado en 2018

Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients

article

Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients

artículo científico publicado en 2006

Clinical validation of saquinavir/ritonavir genotypic resistance score in protease-inhibitor-experienced patients

scientific article published on 01 January 2007

Clinically relevant genotype interpretation of resistance to didanosine

artículo científico publicado en 2005

Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients

artículo científico publicado en 2004

Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir

artículo científico publicado en 2008

Clonal analyses of HIV quasispecies in patients harbouring plasma genotype with K65R mutation associated with thymidine analogue mutations or L74V substitution

artículo científico publicado en 2005

Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19

artículo científico publicado en 2020

Combination of two pathways involved in raltegravir resistance confers dolutegravir resistance

artículo científico publicado en 2015

Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study

artículo científico publicado en 2014

Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes

artículo científico publicado en 2014

Comparison of tests and procedures to build clinically relevant genotypic scores: application to the Jaguar study.

artículo científico publicado en 2005

Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapy.

artículo científico publicado en 2004

Comparison of two genotypic algorithms to determine HIV-1 tropism

artículo científico publicado en 2008

Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital

scientific article published on 18 June 2020

Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine

artículo científico publicado en 2011

Connection domain mutations during antiretroviral treatment failure in Mali: frequencies and impact on reverse transcriptase inhibitor activity

artículo científico publicado en 2012

Coreceptor usage in different reservoirs

artículo científico publicado en 2012

Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Experienced (TE) Patients in France

artículo científico publicado en 2015

Cost-effectiveness of dolutegravir/abacavir/lamivudine in HIV-1 treatment-Naive (TN) patients in France

artículo científico publicado en 2017

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

artículo científico publicado en 2015

De Novo HHV-8 tumors induced by rituximab in autoimmune or inflammatory systemic diseases

artículo científico publicado en 2017

Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes

artículo científico publicado en 2013

Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma

article

Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002-2011 survey

artículo científico publicado en 2012

Detection of human herpesviruses HHV-6, HHV-7 and HHV-8 in whole blood by real-time PCR using the new CMV, HHV-6, 7, 8 R-gene kit.

artículo científico publicado en 2008

Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression

artículo científico publicado en 2016

Didanosine in HIV-1-infected patients experiencing failure of antiretroviral therapy: a randomized placebo-controlled trial

artículo científico publicado en 2005

Differential impact of APOBEC3-driven mutagenesis on HIV evolution in diverse anatomical compartments

artículo científico publicado en 2014

Direct quantification of cell-associated HIV DNA in isolated rectal and blood memory CD4 T cells revealed their similar and low infection levels in long-term treated HIV-infected patients

artículo científico publicado en 2013

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

article

Docking analysis and resistance evaluation of clinically relevant mutations associated with the HIV-1 non-nucleoside reverse transcriptase inhibitors nevirapine, efavirenz and etravirine

artículo científico publicado en 2011

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study

scientific article published in 2019

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-author

scientific article published on 20 September 2020

Dual therapy with lamivudine + protease inhibitor during pregnancy for prevention of mother-to-child transmission of HIV-1.

artículo científico publicado en 2013

E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

artículo científico publicado en 2012

E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations

artículo científico publicado en 2011

Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19

artículo científico publicado en 2020

Effect of antiretroviral drugs on the quality of semen

artículo científico publicado en 2011

Effect of lentivirus encoding HIV-1 Nef-U3 shRNA on the function of HIV-specific memory CD4(+) T cells in patients with chronic HIV-1 infection

artículo científico publicado en 2009

Effects of cyclosporine and hydrocortisone on Kaposi's sarcoma-associated herpesvirus genome replication and cell apoptosis induction ⬇️

artículo científico publicado el 27 de noviembre de 2001

Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, ra

artículo científico publicado en 2016

Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.

artículo científico publicado en 2003

Efficacy of PI monotherapy versus triple therapy for 1964 patients in 10 randomised trials

artículo científico publicado en 2014

Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.

artículo científico publicado en 2010

Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data

artículo científico publicado en 2015

Efficacy of interferon-alpha for the treatment of Kaposi's sarcoma herpesvirus-associated uveitis.

artículo científico publicado en 2005

Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials

artículo científico publicado en 2015

Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity score

artículo científico publicado en 2013

Emergence of cytomegalovirus resistance to foscarnet in a patient receiving foscarnet salvage therapy for multidrug-resistant HIV infection

article

Emerging mutations and associated factors in patients displaying treatment failure on an etravirine-containing regimen

artículo científico publicado en 2012

Etravirine Concentrations in the Cervicovaginal Compartment in HIV-1-Infected Women Receiving Etravirine-Containing Antiretroviral Therapy: DIVA 02 Study ⬇️

artículo científico publicado el 23 de abril de 2012

European Antibiotic Awareness Day: What is new in France?

artículo científico publicado en 2015

Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali

artículo científico publicado en 2019

Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants.

artículo científico publicado en 2018

Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study

artículo científico publicado en 2010

Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.

artículo científico publicado en 2008

Evolution of the K65R, K103N and M184V/I reverse transcriptase mutations in HIV-1-infected patients experiencing virological failure between 2005 and 2010.

artículo científico publicado en 2013

Experience of Indinavir/Ritonavir 400/100 mg Twice-Daily Highly Active Antiretroviral Therapy-Containing Regimen in HIV-1-Infected Patients in Bamako, Mali

article

Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesions

artículo científico publicado en 2016

External Validation of Atazanavir/Ritonavir Genotypic Score in HIV-1 Protease Inhibitor-Experienced Patients

article

Factors Associated With Virological Failure in HIV-1–Infected Patients Receiving Darunavir/Ritonavir Monotherapy

article

Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy

artículo científico publicado en 2013

Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists

artículo científico publicado en 2010

Factors associated with the selection of mutations conferring resistance to protease inhibitors (PIs) in PI-experienced patients displaying treatment failure on darunavir

artículo científico publicado en 2007

Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients

artículo científico publicado en 2009

Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient

scientific article published on 28 April 2020

Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients

artículo científico publicado en 2004

Frequency of amino acid changes associated with resistance to attachment inhibitor BMS-626529 in R5- and X4-tropic HIV-1 subtype B.

artículo científico publicado en 2013

Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients

scientific article published on 10 March 2020

G118R and F121Y mutations identified in patients failing raltegravir treatment confer dolutegravir resistance.

artículo científico publicado en 2014

GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy

artículo científico publicado en 2004

Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes

artículo científico publicado en 2014

Genetic barrier to the development of resistance to rilpivirine and etravirine between HIV-1 subtypes CRF02_AG and B.

artículo científico publicado en 2013

Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes

artículo científico publicado en 2009

Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali

artículo científico publicado en 2007

Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients

artículo científico publicado en 2003

Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trials

artículo científico publicado en 2008

HIV Replication Is Not Controlled by CD8+ T Cells during the Acute Phase of the Infection in Humanized Mice

artículo científico publicado en 2015

HIV and antiretroviral drug distribution in plasma and fat tissue of HIV-infected patients with lipodystrophy

artículo científico publicado en 2002

HIV drug resistance

artículo científico publicado en 2006

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

artículo científico publicado en 2007

HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis

article

HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc

artículo científico publicado en 2015

HIV-1 IN alternative molecular recognition of DNA induced by raltegravir resistance mutations.

artículo científico publicado en 2009

HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART

article

HIV-1 diagnosis with unquantifiable viraemia: don’t be naive, look for antiretroviral drugs

article

HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs

artículo científico publicado en 2012

HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen

artículo científico publicado en 2005

HIV-1 or hepatitis C chronic infection in serodiscordant infertile couples has no impact on infertility treatment outcome

artículo científico publicado en 2009

HIV-1 protease, Gag and gp41 baseline substitutions associated with virological response to a PI-based regimen

artículo científico publicado en 2019

HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide

artículo científico publicado en 2008

High Rates of Baseline Drug Resistance and Virologic Failure Among ART Naïve HIV-Infected Children in Mali

artículo científico publicado en 2017

High clustering of acute HCV infections and high rate of associated STIs among Parisian HIV-positive male patients

scientific article published on 08 February 2019

High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali

artículo científico publicado en 2014

High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger

artículo científico publicado en 2011

High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.

artículo científico publicado en 2004

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

article

Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies

artículo científico publicado en 2013

Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemia

artículo científico

Human Herpesvirus 8 (HHV8) Transmission and Related Morbidity in Organ Recipients

article

Human herpes virus 8 in HIV and non-HIV infected patients with pulmonary arterial hypertension in France

artículo científico publicado en 2005

Human herpesvirus 8 transfusion transmission in Ghana, an endemic region of West Africa

artículo científico publicado en 2012

Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine

artículo científico publicado en 2002

Human retrovirus-5 and Sjögren's syndrome

artículo científico publicado en 1999

INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels

article

Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active an

artículo científico publicado en 2002

Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors

artículo científico publicado en 2013

Identification of new genotypic cut-off levels to predict the efficacy of lopinavir/ritonavir and darunavir/ritonavir in the TITAN trial.

artículo científico publicado en 2009

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy

artículo científico publicado en 2010

Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?

artículo científico publicado en 2020

Impact of Adding Enfuvirtide to the Predictive Value of the Darunavir Genotypic Resistance Score

artículo científico publicado en 2011

Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen

artículo científico publicado en 2017

Impact of HIV-1 reverse transcriptase polymorphism at codons 211 and 228 on virological response to didanosine.

artículo científico publicado en 2006

Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivo

artículo científico publicado en 2009

Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease

artículo científico publicado en 2008

Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice

artículo científico publicado en 2012

Impact of next generation sequencing defined HIV pre-treatment drug resistance on virological outcomes in the ANRS 12249 treatment as prevention trial

article

Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial

artículo científico publicado en 2002

Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropism

artículo científico publicado en 2011

Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencing

artículo científico publicado en 2015

In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface

artículo científico publicado en 2021

In Silico and In Vitro Comparison of HIV-1 Subtypes B and CRF02_AG Integrases Susceptibility to Integrase Strand Transfer Inhibitors

artículo científico publicado en 2012

Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage

artículo científico publicado en 2015

Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).

artículo científico publicado en 2003

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France

artículo científico publicado en 2010

Inflammation and microbial translocation in treatment-controlled HIV patients

scientific article published on 04 June 2013

Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades

artículo científico publicado en 2015

Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance

artículo científico publicado en 2020

International cohort analysis of the antiviral activities of zidovudine and tenofovir in the presence of the K65R mutation in reverse transcriptase

artículo científico publicado en 2010

Interruption of nonnucleoside reverse transcriptase inhibitor (NNRTI) therapy for 2 months has no effect on levels of human immunodeficiency virus type 1 in plasma of patients harboring viruses with mutations associated with resistance to NNRTIs

artículo científico publicado en 2003

Investigation of Super Learner Methodology on HIV-1 Small Sample: Application on Jaguar Trial Data

artículo científico publicado en 2012

Kaposi's sarcoma associated with previous human herpesvirus 8 infection in heart transplant recipients

artículo científico publicado en 2002

Kaposiʼs sarcoma in HIV-negative men having sex with men

article

Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS-163 ETRAL

scientific article published on 01 April 2019

Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatment

artículo científico publicado en 2014

Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali

artículo científico publicado en 2010

Low Immune Response Rate of HIV-Infected Patients to a Single Injection of Hepatitis A Vaccine

artículo científico publicado en 2020

Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma

artículo científico publicado en 2006

Low frequency of HIV-1 tropism evolution in patients successfully treated for at least 2 years

article

Low frequency of intermittent HIV-1 semen excretion in patients treated with darunavir-ritonavir at 600/100 milligrams twice a day plus two nucleoside reverse transcriptase inhibitors or monotherapy

artículo científico publicado en 2010

Low hepatitis D seroprevalence in blood donors of Bamako, Mali

artículo científico publicado en 2019

Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice

artículo científico publicado en 2015

M184V/I does not impact the efficacy of abacavir/lamivudine/dolutegravir use as switch therapy in virologically suppressed patients

artículo científico publicado en 2020

Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients

artículo científico publicado en 2010

Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study

artículo científico publicado en 2014

Medical Features of COVID-19 and Influenza Infection: A Comparative Study in Paris, France

artículo científico publicado en 2020

Methods comparison for molecular diagnosis of human herpesvirus 8 infections

artículo científico publicado en 2020

Mother-to-child transmission of HIV-1 drug resistance in a French cohort

article

Multicenter assessment of HIV-1 RNA quantitation in semen in the CREAThE network

artículo científico publicado en 2012

Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2

artículo científico publicado en 2020

Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load

artículo científico publicado en 2017

Multicenter quality control of the detection of HIV-1 genome in semen before medically assisted procreation

artículo científico publicado en 2006

Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells

artículo científico publicado en 2007

Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors

artículo científico publicado en 2017

Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro

artículo científico publicado en 2008

Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients

artículo científico publicado en 2009

NRTI-sparing regimens yield higher rates of drug resistance than NRTI-based regimens for HIV-1 treatment.

artículo científico publicado en 2013

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

artículo científico publicado en 2013

National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutation

artículo científico publicado en 2008

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism

artículo científico publicado en 2012

Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing

artículo científico publicado en 2018

Neutrophil-Platelet and Monocyte-Platelet Aggregates in COVID-19 Patients

artículo científico publicado en 2020

New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017

scientific article published on 01 September 2019

New Kaposi's sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies

artículo científico publicado en 2020

New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations

scientific article published on 01 July 2019

New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors

artículo científico publicado en 2014

New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T)

scientific article published on 27 November 2018

No HIV-1 molecular evolution on long term antiretroviral therapy initiated during primary HIV-1 infection

artículo científico publicado en 2020

No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir

artículo científico publicado en 2017

Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibit

artículo científico publicado en 2009

Once-daily etravirine/raltegravir (400/800 mg q24h) dual therapy maintains viral suppression over 48 weeks in HIV-infected patients switching from a twice-daily etravirine/raltegravir (200/400 mg q12h) regimen

artículo científico publicado en 2020

Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretrovirals

artículo científico publicado en 2010

Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance

artículo científico publicado en 2018

Patient-selected treatment partners did not protect against drug resistance during first-line NNRTI-based HAART in a randomized trial

artículo científico publicado en 2010

Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission

artículo científico

Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients

artículo científico publicado en 2010

Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial

artículo científico publicado en 2016

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

artículo científico publicado en 2018

Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection

artículo científico publicado en 2006

Pitfalls of HIV genotypic tropism testing after treatment interruption

article

Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study: Figure 1

artículo científico publicado en 2015

Positive impact of HIV-1 gag cleavage site mutations on the virological response to darunavir boosted with ritonavir

artículo científico publicado en 2011

Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART

article

Predictive genotypic algorithm for virologic response to lopinavir-ritonavir in protease inhibitor-experienced patients

artículo científico publicado en 2007

Predictors of virologic response to ritonavir-boosted protease inhibitors

artículo científico publicado en 2005

Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma

artículo científico publicado en 2009

Presence of Minority Resistant Variants After Failure of a Tenofovir, Emtricitabine, and Rilpivirine Regimen

artículo científico publicado en 2016

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study

artículo científico publicado en 2013

Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study

artículo científico publicado en 2007

Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy

scientific article published on 01 April 2020

Prevalence of human herpesvirus 8 antibodies in human immunodeficiency virus type 1-infected homosexual men in Slovakia

artículo científico publicado el 1 de abril de 1998

Prevalence of human herpesvirus 8 infection measured by antibodies to a latent nuclear antigen in patients with various dermatologic diseases

artículo científico publicado en 1998

Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses

artículo científico publicado en 2013

Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients

article

Prevalences of herpesviruses DNA sequences in salivary gland biopsies from primary and secondary Sjögren's syndrome using degenerated consensus PCR primers

artículo científico publicado en 2003

Previously unreported emergence of A265V substitution in the integrase gene in association with bictegravir virological failure

artículo científico publicado en 2020

Primary effusion lymphoma in two kidney transplant recipients

artículo científico publicado en 2010

Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients

artículo científico publicado en 2008

Primary genotypic resistance of HIV-1 to the maturation inhibitor PA-457 in protease inhibitor-experienced patients

artículo científico publicado en 2007

Primary infection with human herpesvirus 8 in an HIV-1-infected patient

article

Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma

artículo científico publicado en 2002

Pulmonary manifestations of human herpesvirus-8 during HIV infection.

artículo científico

Qualitative and quantitative HIV antibodies and viral reservoir size characterization in vertically infected children with virological suppression

artículo científico publicado en 2016

Quality of life improvement in HIV-1 patients treated with raltegravir in a real-life observational study: RACING.

artículo científico publicado en 2017

Quantification of Kaposi's Sarcoma-Associated Herpesvirus in Blood, Oral Mucosa, and Saliva in Patients with Kaposi's Sarcoma

artículo científico publicado en 2004

Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients

artículo científico publicado en 2009

Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients

artículo científico publicado en 2010

Raltegravir concentrations in the genital tract of HIV-1-infected women treated with a raltegravir-containing regimen (DIVA 01 study)

artículo científico publicado en 2011

Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drug

artículo científico publicado en 2009

Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers

artículo científico publicado en 2021

Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept study

artículo científico publicado en 2014

Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients

article

Recurrence and Occurrence of Kaposi's Sarcoma in Patients Living With Human Immunodeficiency Virus (HIV) and on Antiretroviral Therapy, Despite Suppressed HIV Viremia

artículo científico publicado en 2019

Relationship between Kaposi's sarcoma, Kaposi's sarcoma-associated herpesvirus and AIDS dementia complex

artículo científico publicado en 2000

Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in naïve and pre-treated HIV infected patients

article

Relationship between the Quantity of Kaposi Sarcoma–Associated Herpesvirus (KSHV) in Peripheral Blood and Effusion Fluid Samples and KSHV‐Associated Disease

artículo científico publicado en 2007

Remdesivir failure with SARS-CoV-2 RNA-dependent RNA-polymerase mutation in a B-cell immunodeficient patient with protracted Covid-19

scientific article published on 28 September 2020

Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance

article

Reply to Das and Berkhout, "How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir".

artículo científico publicado en 2018

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

artículo científico publicado en 2015

Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients

artículo científico publicado en 2005

Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients

artículo científico publicado en 2004

Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens

artículo científico publicado en 2012

Resistance to HIV-1 integrase inhibitors: A structural perspective

artículo científico publicado en 2010

Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients

artículo científico publicado en 2019

Resistance to novel drug classes

artículo científico publicado en 2009

Resistance to nucleoside reverse transcriptase inhibitors

Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naïve patients infected with non-B HIV-1 subtypes

artículo científico publicado en 2009

Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapy.

artículo científico publicado en 2012

Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease.

artículo científico publicado en 2005

Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapy

artículo científico publicado en 2013

Risk factors for raltegravir resistance development in clinical practice

article

Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients

artículo científico publicado en 2006

Rituximab therapy for HIV-associated Castleman disease

article

Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitors

artículo científico publicado en 2006

Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1.

artículo científico publicado en 2005

Salivary Lactoferrin Is Recognized by the Human Herpesvirus-8

scientific article published on 01 June 2005

Salvage therapy with atazanavir/ritonavir combined to tenofovir in HIV-infected patients with multiple treatment failures: randomized ANRS 107 trial.

artículo científico publicado en 2006

Scoring methods for building genotypic scores: an application to didanosine resistance in a large derivation set

artículo científico publicado en 2013

Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali

artículo científico publicado en 2019

Seroprevalence of human herpesvirus-8 in healthy subjects and patients with AIDS-associated and classical Kaposi's sarcoma in France

artículo científico publicado el 26 de marzo de 1998

Shared HCV Transmission Networks Among HIV-1-Positive and HIV-1-Negative Men Having Sex With Men by Ultradeep Sequencing

artículo científico publicado en 2019

Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks

artículo científico publicado en 2012

Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors

artículo científico publicado en 2010

Stability of HIV RNA in plasma specimens stored at different temperatures

artículo científico publicado en 2008

State of the Art in HIV Drug Resistance: Science and Technology Knowledge Gap

State of the Art in HIV Drug Resistance: Surveillance and Regional Gaps

article

Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrases

article

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

artículo científico publicado en 2007

Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra study

artículo científico publicado en 2012

Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia

artículo científico publicado en 2015

Systematic review to determine the prevalence of transmitted drug resistance mutations to rilpivirine in HIV-infected treatment-naive persons

artículo científico publicado en 2016

TLR-2 Recognizes Propionibacterium acnes CAMP Factor 1 from Highly Inflammatory Strains

artículo científico publicado en 2016

Tetherin restricts productive HIV-1 cell-to-cell transmission

artículo científico publicado en 2010

The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation

artículo científico publicado en 2009

The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype.

artículo científico publicado en 2011

The first locally acquired novel case of 2019-nCoV infection in a healthcare worker in the Paris area

scientific article published on 25 March 2020

The first reported case and management of multicentric Castleman??s disease associated with Kaposi??s sarcoma in an HIV-2-infected patient

article

The future of integrase inhibitors of HIV-1.

artículo científico

The impact of preexisting or acquired Kaposi sarcoma herpesvirus infection in kidney transplant recipients on morbidity and survival

artículo científico publicado en 2009

The involvement of HIV-1 RNAse H in resistance to nucleoside analogues

artículo científico publicado en 2008

The multifactorial pathways towards resistance to the cytosine analogues emtricitabine and lamivudine: evidences from literature

artículo científico publicado en 2014

Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure

artículo científico publicado en 2004

Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients

artículo científico publicado en 2008

Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab

artículo científico publicado en 2017

Transmission of multidrug-resistant HIV-1: 5 years of immunological and virological survey

article

Transmitted antiretroviral drug resistance in newly HIV-infected and untreated patients in Ségou and Bamako, Mali

artículo científico publicado en 2012

Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation

artículo científico publicado en 2017

Ultradeep sequencing in the therapeutic management of HIV-1 infection at treatment initiation

artículo científico publicado en 2015

Ultradeep sequencing reveals HIV-1 diversity and resistance compartmentalization during HIV-encephalopathy

scientific article published on 21 July 2020

Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies

artículo científico publicado en 2018

Uncommon Detection of Mixed HCV Genotype Infections in Recently Infected Men Who Have Sex with Men

artículo científico publicado en 2019

Upgraded Cobas Ampliprep-Cobas TaqMan version 2.0 HIV-1 RNA quantification assay versus first version: correction of underestimations

artículo científico publicado en 2011

Usefulness of Kaposi sarcoma-associated herpesvirus (KSHV)-DNA viral load in whole blood for the diagnosis and monitoring of KSHV-associated diseases

artículo científico publicado en 2018

Variability of the HIV-1 3' polypurine tract (3'PPT) region and implication in integrase inhibitor resistance

artículo científico publicado en 2019

Very early ART resulting in the absence of HIV-1 antibodies and in a sustained undetectable plasma HIV-1-RNA and proviral-DNA in an HLA-B*5701 and Δ32 heterozygote HIV-1-infected patient was not associated with functional cure

artículo científico publicado en 2014

Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level

artículo científico publicado en 2004

Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).

artículo científico publicado en 2005

Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients

artículo científico publicado en 2005

Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).

artículo científico publicado en 2015

Virological failure of patients on maraviroc-based antiretroviral therapy

artículo científico publicado en 2015

[HPV and cancer]

scientific article published on 01 January 2005

iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda